Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Prostate Cancer”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Not applicableUnknownNCT03701659
What this trial is testing

TUPKRP Combined With MAB Therapy for LUTS/PCa

Who this might be right for
Advanced Prostate CancerLower Urinary Tract SymptomsQuality of Life+2 more
The Third Xiangya Hospital of Central South University 100
Testing effectiveness (Phase 2)Study completedNCT03348527
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Lidds AB 61
Testing effectiveness (Phase 2)Looking for participantsNCT03899077
What this trial is testing

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

Who this might be right for
Cancer of Prostate
Cancer Research Antwerp 202
Testing effectiveness (Phase 2)Study completedNCT03456804
What this trial is testing

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 13
Large-scale testing (Phase 3)Looking for participantsNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 392
Testing effectiveness (Phase 2)Study completedNCT00970203
What this trial is testing

Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Who this might be right for
Cancer of ProstateCancer of the ProstateNeoplasms, Prostate+4 more
Roswell Park Cancer Institute 13
Not applicableLooking for participantsNCT05931419
What this trial is testing

High-Risk prostatE Cancer radiatiOn Versus surgERy

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Comprehensive Cancer Centre The Netherlands 837
Early research (Phase 1)Study completedNCT03751436
What this trial is testing

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+6 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05751434
What this trial is testing

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaLocalized Prostate Carcinoma
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT05191680
What this trial is testing

TherApeutics in Early ProState Cancer (TAPS02)

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 90
Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Large-scale testing (Phase 3)UnknownNCT01864096
What this trial is testing

The Metformin Active Surveillance Trial (MAST) Study

Who this might be right for
Prostate Cancer
University Health Network, Toronto 408
Early research (Phase 1)Study completedNCT01692262
What this trial is testing

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,+3 more
AstraZeneca 59
Testing effectiveness (Phase 2)Study completedNCT01204710
What this trial is testing

Olaratumab (IMC-3G3) in Prostate Cancer

Who this might be right for
Prostate Cancer
Eli Lilly and Company 123
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01750866
What this trial is testing

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Metastatic Prostate Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03002220
What this trial is testing

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Who this might be right for
Prostate Cancer
MedSIR 52
Testing effectiveness (Phase 2)UnknownNCT01883128
What this trial is testing

FOcal RECurrent Assessment and Salvage Treatment

Who this might be right for
Progression of Prostate Cancer
University College London Hospitals 177
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Load More Results